Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Head and Neck Oncology
  •  Gynecological Cancers
  •  Adjuvant Therapy
  •  Carcinomas
  •  Urological Cancers
  •  Gastrointestinal Cancer
  •  Chemoprevention
  •  Cervical Cancer


Citation: Clin Oncol. 2022;7(1):1934.DOI: 10.25107/2474-1663.1934

Influence of Hypertension and Diabetes on Postoperative Outcomes in Cancer Patients Undergoing Moderate/High Risk Surgical Procedures

Lafayete William Ferreira Ramos, Beatriz Nery Nascimento, Gabriel Rossi Silva, Marcos Vinícius Ferreira Ramos, Barbara Cristina Ferreira Ramos, Cristiano Freitas de Souza and Pedro Amoedo Fernandes

São Camilo Oncologia, São Paulo, Brazil
Centro Universitário São Camilo, São Paulo, Brazil
Faculty of Medicine of Marilia, Marília, Brazil

*Correspondance to: Lafayete William Ferreira Ramos 

 PDF  Full Text Research Article | Open Access


Background: Systemic Hypertension (HTN) and Diabetes Mellitus (DM) are believed to be risk factors for adverse postoperative outcomes in patients undergoing surgical interventions, but evidence is lacking. This retrospective study evaluated the effects of HTN and DM, alone or in combination, on postoperative outcomes of elective non-cardiac surgery in cancer patients.
Materials and Methods: Patients (n=844) with malignancies, who underwent elective surgery at a tertiary hospital, were categorized into healthy (group A, n=339), hypertensive (group B, n=357), diabetic (group C, n=21), and hypertensive and diabetic (group D, n=127) groups. Preoperatively, all patients had systolic blood pressure ≤ 160 mmHg and plasma glucose level ≤ 140 mg/dl. Postoperative in-hospital morbidity and mortality were compared among groups.
Results: Postoperative complications occurred in 22 (6.5%), 21 (5.9%), 2 (9.5%), and 11 (8.7%) patients in groups A, B, C, and D, respectively (p=0.712). HTN (p=0.538), DM (p=0.990), and HTN+DM (p=0.135) did not impact the occurrence of adverse events. Patients with higher surgical risk (ASA III or IV) and those with longer surgical time had higher morbidity and mortality
(p=0.001, p<0.001, respectively). In multiple logistic regression analysis, ASA status and surgical time were independent risk factors for postoperative complications (both p<0.001).
Conclusion: Cancer patients with preoperative comorbidities, such as HTN and DM, alone or in combination, regardless of other characteristics, do not have an increased risk of adverse postoperative outcomes.


Diabetes mellitus; Hypertension; Oncologic surgery; Postoperative outcomes

Cite the Article:

Ramos LWF, Nascimento BN, Silva GR, Ramos MVF, Ramos BCF, de Souza CF, et al. Influence of Hypertension and Diabetes on Postoperative Outcomes in Cancer Patients Undergoing Moderate/High Risk Surgical Procedures. Clin Oncol. 2022;7:1934..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Delivered Dose Verification for Lung Cancer Stereotactic Body Radiotherapy Using Cone-Beam CT
 Abstract  PDF  Full Text
Clinical and Morphological Heterogeneity of the Xp11.2 Translocation Renal Cell Carcinoma
 Abstract  PDF  Full Text
View More...